Vendor review
Haikou Mingheng Biotechnology reviews
Haikou Mingheng Biotechnology reviews from 33 independent lab tests (Tirzepatide, Retatrutide and Cagrilintide): grade A, purity and fill accuracy. Is Haikou Mingheng Biotechnology legit? See what its vials showed.
What the lab tests show
33 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Sep 21, 2026 | Tirzepatide | 100 % | 32.39 mg of 40 mg (-19 %) | Pass | View |
| Sep 16, 2026 | Retatrutide | 95.72 % | 15.6737 mg of 15 mg (4 %) | Pass | View |
| Sep 16, 2026 | Retatrutide | 86.53 % | 27.2072 mg of 30 mg (-9 %) | Pass | View |
| Sep 15, 2026 | GHK-Cu | 99.9 % | 44.8 mg of 50 mg (-10 %) | Pass | View |
| Aug 9, 2026 | Tirzepatide | 99.8 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Jun 16, 2026 | Tirzepatide | 99.9 % | 15.3 mg of 15 mg (2 %) | Pass | View |
| May 20, 2026 | Retatrutide | 99.9 % | 31.4 mg of 30 mg (5 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 9.68 mg of 10 mg (-3 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 28.2 mg of 30 mg (-6 %) | Pass | View |
| Apr 28, 2026 | Cagrilintide | 99.9 % | 4.82 mg of 5 mg (-4 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 26.8 mg of 30 mg (-11 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 14 mg of 15 mg (-7 %) | Pass | View |
| Mar 18, 2026 | GHK-Cu | 99.9 % | 95 mg of 100 mg (-5 %) | Pass | View |
| Mar 10, 2026 | Tirzepatide | 99.9 % | 33.1 mg of 30 mg (10 %) | Pass | View |
| Mar 10, 2026 | Retatrutide | 99.9 % | 10.9 mg of 20 mg (-46 %) | Pass | View |
| Mar 10, 2026 | Cagrilintide | 99.9 % | 2.05 mg of 2 mg (2 %) | Pass | View |
| Mar 1, 2026 | Tirzepatide | 99.8 % | 31.5 mg of 30 mg (5 %) | Pass | View |
| Feb 26, 2026 | Cagrilintide | 98.31 % | 2.55 mg of 2 mg (28 %) | Pass | View |
| Feb 26, 2026 | Retatrutide | 96.68 % | 15 mg of 15 mg (0 %) | Pass | View |
| Feb 20, 2026 | Cagrilintide | 97.6 % | 2.52 mg of 2 mg (26 %) | Pass | View |
| Feb 4, 2026 | GHK-Cu | 99.9 % | 45 mg of 50 mg (-10 %) | Pass | View |
| Jan 29, 2026 | Tirzepatide | 99.9 % | 41.6 mg of 30 mg (39 %) | Pass | View |
| Jan 15, 2026 | Tirzepatide | 98.46 % | 6.54 mg of 10 mg (-35 %) | Pass | View |
| Jan 7, 2026 | Retatrutide | 99.6 % | 15.3 mg of 15 mg (2 %) | Pass | View |
| Dec 29, 2025 | Cagrilintide | 99.7 % | 2.01 mg of 2 mg (0 %) | Pass | View |
| Dec 29, 2025 | Cagrilintide | 99.8 % | 5.9 mg of 5 mg (18 %) | Pass | View |
| Nov 25, 2025 | Cagrilintide | 99.95 % | 5.11 mg of 5 mg (2 %) | Pass | View |
| Nov 18, 2025 | Retatrutide | 98.9 % | 5.65 mg of 5 mg (13 %) | Pass | View |
| Nov 6, 2025 | Retatrutide | 99.56 % | 9.59 mg of 10 mg (-4 %) | Pass | View |
| Nov 4, 2025 | Tirzepatide | 99.9 % | 46.13 mg of 40 mg (15 %) | Pass | View |
| Oct 6, 2025 | Tirzepatide | 99.7 % | 46.4 mg of 40 mg (16 %) | Pass | View |
| Sep 18, 2025 | Tirzepatide | 99.95 % | 32.1 mg of 30 mg (7 %) | Pass | View |
| Sep 18, 2025 | Retatrutide | 99.95 % | 28.9 mg of 30 mg (-4 %) | Pass | View |
What Haikou Mingheng Biotechnology sells
No current listings on record.
About Haikou Mingheng Biotechnology
Finnrick has tested 33 samples from Haikou Mingheng Biotechnology across 4 products.